US Patent 7550426 Acetylated therapeutic procytotoxins
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Thomas E. Wagner0
Xianzhong Yu0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+378 characters)
Article
Patent abstract
A class of procytotoxic agents is characterized by a capability to kill with target cell-specificity. Such an aspect can be a pore-forming protein which has at least one lysine residue, modified by a peptide linkage to an amino acid residue, via the epsilon amino group, and an acetyl group. These agents are useful in treating cancer, especially prostate cancer.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07550426 Acetylated therapeutic procytotoxins US Patent 7550426 Acetylated therapeutic procytotoxins
Infobox
Patent Number
075504260
Patent Number
75504260
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075504260
Date of Patent
June 23, 2009
0Patent Application Number
111314430
Date Filed
May 18, 2005
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07550426 Acetylated therapeutic procytotoxins
Infobox
Is a
Patent jurisdiction
Patent number
07550426
Date of patent
June 23, 2009
Patent application number
11131443
Date Filed
May 18, 2005
Patent primary examiner
Find more entities like US Patent 7550426 Acetylated therapeutic procytotoxins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
